CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-06 | Patel Samir Rashmikant Director | Grant or award | +406,250 | $1.12 | $455K | 3,031,005 |
| 2025-03-06 | Patel Samir Rashmikant Director | Grant or award · Series A Warrants (Right to Buy) | +406,250 | $1.12 | $455K | 406,250 |
| 2025-03-06 | Patel Samir Rashmikant Director | Grant or award · Series B Warrants (Right to Buy) | +406,250 | $1.12 | $455K | 406,250 |
| 2025-03-06 | Neal James R Director | Grant or award | +4,464 | $1.12 | $5K | 36,271 |
| 2025-03-06 | Neal James R Director | Grant or award · Series A Warrants (Right to Buy) | +4,464 | $1.12 | $5K | 4,464 |
| 2025-03-06 | Neal James R Director | Grant or award · Series B Warrants (Right to Buy) | +4,464 | $1.12 | $5K | 4,464 |
| 2025-03-06 | Gaslightwala Abizer Director | Grant or award | +133,928 | $1.12 | $150K | 181,428 |
| 2025-03-06 | Gaslightwala Abizer Director | Grant or award · Series A Warrants (Right to Buy) | +133,928 | $1.12 | $150K | 133,928 |
| 2025-03-06 | Gaslightwala Abizer Director | Grant or award · Series B Warrants (Right to Buy) | +133,928 | $1.12 | $150K | 133,928 |
| 2025-03-06 | Bazemore Robert B Director | Grant or award | +44,642 | $1.12 | $50K | 44,642 |
| 2025-03-06 | Bazemore Robert B Director | Grant or award · Series A Warrants (Right to Buy) | +44,642 | $1.12 | $50K | 44,642 |
| 2025-03-06 | Bazemore Robert B Director | Grant or award · Series B Warrants (Right to Buy) | +44,642 | $1.12 | $50K | 44,642 |
| 2025-01-10 | Gaslightwala Abizer Director | Grant or award | +11,640 | $1.22 | $14K | 47,500 |
| 2025-01-10 | Gaslightwala Abizer Director | Grant or award | +11,439 | $1.22 | $14K | 35,860 |
| 2025-01-10 | Hombeck Torsten CFO | Grant or award | +200 | $1.22 | $244 | 200 |
| 2025-01-09 | Neal James R Director | Grant or award | +8,000,000 | $0.00 | $5K | 32,216,000 |
| 2025-01-03 | Gaslightwala Abizer Director | Grant or award | +1,720,000 | $0.00 | $1K | 71,720,000 |
| 2025-01-03 | Patel Samir Rashmikant Director | Grant or award | +208,000 | $0.00 | $125 | 5,249,511,500 |
| 2025-01-03 | Patel Samir Rashmikant Director | Grant or award · Stock Option (Right to Buy) | +152,672,000 | 152,672,000 | ||
| 2024-12-27 | Patel Samir Rashmikant Director | Grant or award | +400,000 | $0.00 | $200 | 5,249,303,500 |
Page 7 of 11 · 216 trades